LMAN2L expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.744800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.008800E-01
Normal-vs-Stage2
6.115600E-01
Normal-vs-Stage3
3.152800E-01
Normal-vs-Stage4
5.556600E-01
Stage1-vs-Stage2
7.905200E-01
Stage1-vs-Stage3
1.918170E-02
Stage1-vs-Stage4
4.497800E-01
Stage2-vs-Stage3
8.828100E-02
Stage2-vs-Stage4
4.520600E-01
Stage3-vs-Stage4
1.147990E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.699800E-01
Normal-vs-AfricanAmerican
5.735600E-01
Normal-vs-Asian
8.850600E-01
Caucasian-vs-AfricanAmerican
8.416200E-01
Caucasian-vs-Asian
4.258400E-01
AfricanAmerican-vs-Asian
6.954400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.995000E-01
Normal-vs-Female
6.982600E-01
Male-vs-Female
1.409030E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.713960E-01
Normal-vs-Age(41-60Yrs)
2.646000E-01
Normal-vs-Age(61-80Yrs)
7.924600E-01
Normal-vs-Age(81-100Yrs)
8.388200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.794000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.312400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.494300E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.824730E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.683500E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.233000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.001200E-01
Normal-vs-Daily Drinker
7.135000E-01
Normal-vs-Weekly Drinker
8.477000E-01
Normal-vs-Occasional Drinker
2.640400E-01
Normal-vs-Social Drinker
3.887800E-01
Non Drinker-vs-Daily Drinker
7.139800E-01
Non Drinker-vs-Weekly Drinker
9.390800E-01
Non Drinker-vs-Occasional Drinker
1.924270E-02
Non Drinker-vs-Social Drinker
2.890200E-01
Daily Drinker-vs-Weekly Drinker
7.927600E-01
Daily Drinker-vs-Occasional Drinker
2.752500E-02
Daily Drinker-vs-Social Drinker
4.822400E-01
Weekly Drinker-vs-Occasional Drinker
2.451700E-02
Weekly Drinker-vs-Social Drinker
3.815800E-01
Occasional Drinker-vs-Social Drinker
5.573900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.996200E-01
Normal-vs-Grade 2
9.884000E-01
Normal-vs-Grade 3
9.351400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.132600E-01
Grade 1-vs-Grade 3
8.053400E-01
Grade 1-vs-Grade 4
8.996200E-01
Grade 2-vs-Grade 3
2.879000E-01
Grade 2-vs-Grade 4
9.884000E-01
Grade 3-vs-Grade 4
9.351400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.149600E-01
Normal-vs-NonDiabetic
4.904600E-01
Diabetic-vs-NonDiabetic
1.043220E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.150400E-01
Normal-vs-NoPancreatitis
5.833000E-01
Pancreatitis-vs-NoPancreatitis
7.078800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.780200E-01
Normal-vs-N1
5.601400E-01
N0-vs-N1
7.284200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.189200E-01
Normal-vs-TP53-NonMutant
8.113600E-01
TP53-Mutant-vs-TP53-NonMutant
1.283540E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
